Carlo Incerti

Carlo Incerti, President of MolMed since September 2018, graduated in Medicine and Surgery in 1984 at the University of Modena. He most recently held the position of Head of Global Medical Affairs at Sanofi Genzyme and Chief Medical Officer, with oversight of 4 therapeutic areas: oncology, immunology, multiple sclerosis and rare diseases. He is Member of the Board of EuropaBio, the European Association for Bioindustries, and member of the Governing Board of IMI (Innovative Medicine Initiative), the largest public-private venture in the area of healthcare research, founded in 2008 thanks to a collaboration between the European Commission and the association of the European pharmaceutical industries (European Federation of Pharmaceutical Industries and Associations - EFPIA), with the aim of fostering innovation in the drug research and development process to satisfy unmet medical needs.